Recent Quotes (30 days)

You have no recent quotes
chg | %

Medical Developments International Ltd  

(Public, ASX:MVP)   Watch this stock  
Find more results for ASX: MVP
+0.06 (0.83%)
Delayed:   12:46PM GMT+11
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 7.17 - 7.32
52 week 4.59 - 8.07
Open 7.24
Vol / Avg. 31,902.00/99,615.00
Mkt cap 431.41M
P/E 237.55
Div/yield 0.02/0.55
EPS 0.03
Shares 59.10M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 13.70% 9.91%
Operating margin 18.61% 13.42%
EBITD margin - 20.72%
Return on average assets 6.89% 4.39%
Return on average equity 13.25% 8.96%
CDP Score - -


4 Caribbean Dr
+61-3-95471888 (Phone)
+61-3-95470262 (Fax)

Website links


Medical Developments International Limited is an Australia-based healthcare company. The Company is engaged in the manufacture and distribution of a pharmaceutical drug, and medical and veterinary equipment. The Company operates through three segments: Pharmaceuticals, Medical Devices and Veterinary products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia and the United Kingdom, and some sales in New Zealand, Eastern Europe, the Middle East and South America. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia and New Zealand, and some sales in Asia, Europe, the Middle East and North America. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe and the United States. The Company offers a range of products in the areas of pain management, and asthma and resuscitation.

Officers and directors

John Stewart Sharman Chief Executive Officer
Mark Edwards Company Secretary
David John Williams Non-Executive Chairman of the Board
Age: 60
Allan D. McCallum Non-Executive Director
Harry F. Oxer Non-Executive Director
Philip Powell Non-Executive Director
Leon Hoare Independent Non-Executive Director